跳至主要内容
临床试验/IRCT20170609034406N4
IRCT20170609034406N4已完成2 期

The effect of probiotic (Saccharomycesboulardi) on uremic toxins and quality of life in patients with chronic hemodialysis.

Tabriz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age over 18 years
  • Begining of hemodialysis from previous 3 months for three times a week
  • Ability to understand and sign a consent form
  • Use of biocompatible dialysis membrane
  • Properly functioning arteriovenous fistula or catheter

排除标准

  • Pregnancy and lactation
  • Use of broad-spectrum antibiotics in the last 3 months or now
  • Allergy to probiotics
  • The presence of any chronic, active, uncontrolled or severe chronic inflammatory disease (autoimmune diseases, connective tissue disease, malignancy, HIV, liver disease and pulmonary disease)
  • The presence of chronic or acute infection in a recent month
  • Concurrently presence in another trial (drug or supplement)
  • A history of stroke or myocardial infarction in the last 3 months
  • Receiving medications which are effective on inflammatory factors (corticosteroids or other immunosuppressive drugs, nonsteroidal anti-inflammatory drugs, contraceptives, pentoxifylline)

研究者

相似试验